프로그램

일시 : 2021년 3월 20일(토) *실시간 온라인 컨퍼런스

  Morning Scientific Symposium 좌장: 강진형 (서울성모병원)
08:50~09:30 First-line brigatinib for ALK-positive NSCLC: a paradigm shift and clinical experience 김태민 (서울대병원)
  Plenary Session  
  Diagnosis & Monitoring of Lung Cancer  좌장: 김승준 (서울성모병원)
09:30~09:50 Non-invasive biomarkers in lung cancer management 박찬권 (여의도성모병원)
09:50~10:10 Recent progress of lung cancer screening  전경녀 (창원경상대병원)
10:10~10:30 New WHO classification of lung tumors 김루시아 (인하대병원)
  Treatment of Lung Cancer 좌장: 김상위 (서울아산병원)
10:30~10:50 Surgical role in the era of perioperative immune checkpoint inhibitor 김홍관 (삼성서울병원)
10:50~11:10 New data of precision oncology practice from WCLC 2020 민영주 (울산대병원)
11:10~11:30 Updated clinical trial data of immuno-oncology 김혜련 (세브란스병원)
11:30~11:40 Q&A 
  Scientific Symposium   좌장: 이기형 (충북대병원)
11:40~12:30 Beyond becoming a SOC in mNSCLC treatment, pembrolizumab now opens a new era of More TOMORROWs 이세훈 (삼성서울병원)
12:30~13:00 Break
  Room A Room B Room C
Parallel Session Multidisciplinary: Expanding Indication of Local Therapy in Lung Cancer

좌장: 김연실 (서울성모병원)

  Imaging and Screening

좌장: 김윤현 (전남대병원)

13:00~13:20
Radiofrequency ablation as lung cancer treatment

진공용 (전북대병원)

  13:00~13:25
Screening and early detection-lung cancer screening programs

임재광 (경북대병원)

13:20~13:40
Radiotherapy in early stage and oligomets

임채홍 (고려대안산병원)

13:25~13:50
Screening and early detection -risk modelling and artificial intelligence

남주강 (서울대병원)

13:40~14:00
Limited surgery not limited to local disease

김현구 (고려대구로병원)

13:50~14:15
Screening and early detection -radiological risk stratification

이종은 (전남대병원)

14:00~14:20 Discussion 14:15~14:20 Discussion
Advanced NSCLC

좌장: 심병용 (성빈센트병원)

Pulmonology

좌장: 장승훈 (한림대성심병원)

Pathology & Biomarker Discovery

좌장: 이건국 (국립암센터)

14:20~14:50
Immunotherapy

박건욱 (계명대동산병원)

14:20~14:40
Something new in palliative and supportive care

여창동 (은평성모병원)

14:20~14:40
The new WHO classification of lung tumors

심효섭 (세브란스병원)

14:40~15:00
Tumor biology and advances in omics

이정은 (충남대병원)

14:40~15:00
Getting all NSCLCs genotyped: how can we get to 100%?

김태정 (여의도성모병원)

14:50~15:20
New data from rare EGFR Alterations

이윤규 (강북삼성병원)

15:00~15:20
Technological advances in diagnostics for lung cancer

김혜련 (원자력병원)

15:00~15:20
Advances in biomarkers for immune checkpoint blockade and targeted therapy in non small cell lung carcinoma

최윤라 (삼성서울병원)

15:20~15:30Discussion   15:20~15:30 Discussion 15:20~15:30 Discussion
15:30~16:00 Break
Thoracic Malignancies

좌장: 이대호 (서울아산병원)

Thoracic Surgical Oncology

좌장: 강창현 (서울대병원)

Update in Radiation Oncology

좌장: 문성호 (국립암센터)

16:00~16:20
Small cell lung cancer

임선민 (세브란스병원)

16:00~16:20
- Strategies for metachronous second primary lung cancer

조종호 (삼성서울병원)

16:00~16:20
Radiotherapy for LA-NSCLC

송창훈 (분당서울대병원)

16:20~16:45
Thymic malignacy/mesothelioma

박세훈 (삼성서울병원)

16:20~16:40
- Chracterization and classification of oligometastatic disease & surgery as a component of local consolidative therapy

이근동 (서울아산병원)

16:20~16:40
New trends of radiotherapy in lung cancer

윤홍인 (세브란스병원)

16:45~17:00
New challenges during COVID-19

강은주 (고려대구로병원)

16:40~17:00
- Updates on surgery of small cell lung cancer

박성용 (세브란스병원)

16:40~17:00
Radiotherapy for SCLC and other thoracic tumors (mesothelioma / thymoma)

곽유강 (인천성모병원)

17:00~17:10 Discussion 17:00~17:10 Discussion 17:00~17:10 Discussion
Copyright (c) 2013 by Korean Society of Medical Oncology. All rights reserved.
03186 서울특별시 종로구 새문안로 92 (신문로1가 163) 광화문오피시아빌딩 2220호 TEL : 02-735-2857 FAX : 02-735-2856 E-mail : ksmo@ksmo.or.kr